Aplenzin (bupropion hydrobromide ER) / Bausch Health  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Aplenzin (bupropion hydrobromide ER) / Bausch Health
NCT00991081: Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.

Completed
4
36
US
Counseling, Motivational interviewing, Motivational enhancement, Self-help guide, Support Materials, Clearing the Air, Pharmacotherapy, NRT, Nicotine Replacement Therapy, The Patch, Bupropion, Zyban, Aplenzin, Wellbutrin, Genetic feedback, verbal, Pharmacogenetics, Pharmacogenetic counseling, Genetic feedback, printed, Pharmacogenetic Feedback
Stanford University, SRI International, Johns Hopkins University, University of Bristol, National Institute on Drug Abuse (NIDA)
Smoking
03/11
03/11
NCT02129751: Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder

Not yet recruiting
4
200
US
bupropion hydrobromide, Aplenzin, Placebo
Bausch Health Americas, Inc.
Major Depressive Disorder
11/24
11/24

Download Options